US Stock MarketDetailed Quotes

MIRA Pharmaceuticals (MIRA)

Watchlist
  • 1.020
  • -0.030-2.86%
Close Apr 27 16:00 ET
  • 1.030
  • +0.010+0.98%
Post 19:59 ET
42.86MMarket Cap-0.76P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

MIRA Pharmaceuticals (MIRA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
30.86%10.49M
138.94%5.82M
-36.73%1.32M
-10.67%1.55M
2.09%1.81M
-5.95%8.02M
-20.24%2.44M
-34.13%2.08M
78.38%1.73M
32.01%1.77M
Selling and administrative expenses
86.16%8.77M
238.01%5.33M
-10.83%904.35K
-5.94%1.05M
48.20%1.49M
-27.49%4.71M
-40.94%1.58M
-52.71%1.01M
4.20%1.12M
63.77%1.01M
-General and administrative expense
86.16%8.77M
238.01%5.33M
-10.83%904.35K
-5.94%1.05M
48.20%1.49M
-27.49%4.71M
-40.94%1.58M
-52.71%1.01M
4.20%1.12M
63.77%1.01M
Research and development costs
-47.97%1.72M
-42.36%496.54K
-61.34%412.64K
-19.25%496.2K
-58.75%314.4K
110.15%3.31M
122.52%861.44K
5.14%1.07M
708.26%614.46K
180.66%762.28K
Operating profit
-30.86%-10.49M
-138.94%-5.82M
36.73%-1.32M
10.67%-1.55M
-2.09%-1.81M
5.95%-8.02M
20.24%-2.44M
34.13%-2.08M
-78.38%-1.73M
-32.01%-1.77M
Net non-operating interest income expense
-40.30%98.91K
39.54%53.17K
-58.42%15.7K
-78.44%8.5K
-57.51%21.42K
104.79%165.67K
101.40%38.11K
108.83%37.75K
113.31%39.4K
3,149.97%50.42K
Non-operating interest income
-40.30%98.91K
39.54%53.17K
-58.42%15.7K
-78.44%8.5K
-57.51%21.42K
--165.67K
--38.11K
--37.75K
--39.4K
--50.42K
Total other finance cost
----
----
----
----
----
-104.79%-165.67K
-101.40%-38.11K
-108.83%-37.75K
----
-3,149.97%-50.42K
Other net income (expense)
-48.28K
-211.66K
163.62K
-107
Gain on sale of security
---35.21K
---211.27K
--176.06K
----
----
----
----
----
----
----
Other non- operating income (expenses)
---13.07K
---396
---12.44K
---107
----
----
----
----
----
----
Income before tax
-32.98%-10.44M
-149.34%-5.98M
44.34%-1.14M
9.08%-1.54M
-3.84%-1.78M
34.46%-7.85M
58.54%-2.4M
43.03%-2.04M
-33.58%-1.69M
-28.09%-1.72M
Income tax
Net income
-32.98%-10.44M
-149.34%-5.98M
44.34%-1.14M
9.08%-1.54M
-3.84%-1.78M
34.46%-7.85M
58.54%-2.4M
43.03%-2.04M
-33.58%-1.69M
-28.09%-1.72M
Net income continuous Operations
-32.98%-10.44M
-149.34%-5.98M
44.34%-1.14M
9.08%-1.54M
-3.84%-1.78M
34.46%-7.85M
58.54%-2.4M
43.03%-2.04M
-33.58%-1.69M
-28.09%-1.72M
Minority interest income
Net income attributable to the parent company
-32.98%-10.44M
-149.34%-5.98M
44.34%-1.14M
9.08%-1.54M
-3.84%-1.78M
34.46%-7.85M
58.54%-2.4M
43.03%-2.04M
-33.58%-1.69M
-28.09%-1.72M
Preferred stock dividends
Other preferred stock dividends
21.56M
0
21.56M
0
0
0
Net income attributable to common stockholders
-307.50%-32M
-149.34%-5.98M
-1,010.37%-22.69M
9.08%-1.54M
-3.84%-1.78M
34.46%-7.85M
58.54%-2.4M
43.03%-2.04M
-33.58%-1.69M
-28.09%-1.72M
Basic earnings per share
-164.71%-1.35
4.89%-0.1427
-742.86%-1.18
18.18%-0.09
26.67%-0.11
40.00%-0.51
62.50%-0.15
46.15%-0.14
-28.11%-0.11
-50.00%-0.15
Diluted earnings per share
-164.71%-1.35
4.89%-0.1427
-742.86%-1.18
18.18%-0.09
26.67%-0.11
40.00%-0.51
62.50%-0.15
46.15%-0.14
-28.11%-0.11
-50.00%-0.15
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 30.86%10.49M138.94%5.82M-36.73%1.32M-10.67%1.55M2.09%1.81M-5.95%8.02M-20.24%2.44M-34.13%2.08M78.38%1.73M32.01%1.77M
Selling and administrative expenses 86.16%8.77M238.01%5.33M-10.83%904.35K-5.94%1.05M48.20%1.49M-27.49%4.71M-40.94%1.58M-52.71%1.01M4.20%1.12M63.77%1.01M
-General and administrative expense 86.16%8.77M238.01%5.33M-10.83%904.35K-5.94%1.05M48.20%1.49M-27.49%4.71M-40.94%1.58M-52.71%1.01M4.20%1.12M63.77%1.01M
Research and development costs -47.97%1.72M-42.36%496.54K-61.34%412.64K-19.25%496.2K-58.75%314.4K110.15%3.31M122.52%861.44K5.14%1.07M708.26%614.46K180.66%762.28K
Operating profit -30.86%-10.49M-138.94%-5.82M36.73%-1.32M10.67%-1.55M-2.09%-1.81M5.95%-8.02M20.24%-2.44M34.13%-2.08M-78.38%-1.73M-32.01%-1.77M
Net non-operating interest income expense -40.30%98.91K39.54%53.17K-58.42%15.7K-78.44%8.5K-57.51%21.42K104.79%165.67K101.40%38.11K108.83%37.75K113.31%39.4K3,149.97%50.42K
Non-operating interest income -40.30%98.91K39.54%53.17K-58.42%15.7K-78.44%8.5K-57.51%21.42K--165.67K--38.11K--37.75K--39.4K--50.42K
Total other finance cost ---------------------104.79%-165.67K-101.40%-38.11K-108.83%-37.75K-----3,149.97%-50.42K
Other net income (expense) -48.28K-211.66K163.62K-107
Gain on sale of security ---35.21K---211.27K--176.06K----------------------------
Other non- operating income (expenses) ---13.07K---396---12.44K---107------------------------
Income before tax -32.98%-10.44M-149.34%-5.98M44.34%-1.14M9.08%-1.54M-3.84%-1.78M34.46%-7.85M58.54%-2.4M43.03%-2.04M-33.58%-1.69M-28.09%-1.72M
Income tax
Net income -32.98%-10.44M-149.34%-5.98M44.34%-1.14M9.08%-1.54M-3.84%-1.78M34.46%-7.85M58.54%-2.4M43.03%-2.04M-33.58%-1.69M-28.09%-1.72M
Net income continuous Operations -32.98%-10.44M-149.34%-5.98M44.34%-1.14M9.08%-1.54M-3.84%-1.78M34.46%-7.85M58.54%-2.4M43.03%-2.04M-33.58%-1.69M-28.09%-1.72M
Minority interest income
Net income attributable to the parent company -32.98%-10.44M-149.34%-5.98M44.34%-1.14M9.08%-1.54M-3.84%-1.78M34.46%-7.85M58.54%-2.4M43.03%-2.04M-33.58%-1.69M-28.09%-1.72M
Preferred stock dividends
Other preferred stock dividends 21.56M021.56M000
Net income attributable to common stockholders -307.50%-32M-149.34%-5.98M-1,010.37%-22.69M9.08%-1.54M-3.84%-1.78M34.46%-7.85M58.54%-2.4M43.03%-2.04M-33.58%-1.69M-28.09%-1.72M
Basic earnings per share -164.71%-1.354.89%-0.1427-742.86%-1.1818.18%-0.0926.67%-0.1140.00%-0.5162.50%-0.1546.15%-0.14-28.11%-0.11-50.00%-0.15
Diluted earnings per share -164.71%-1.354.89%-0.1427-742.86%-1.1818.18%-0.0926.67%-0.1140.00%-0.5162.50%-0.1546.15%-0.14-28.11%-0.11-50.00%-0.15
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +20.72%
Sample Name
Sample Code
 +8.47%
Sample Name
Sample Code
 +7.98%
4
VanEck Oil Services ETF
OIH
+5.58%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.68%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.58%
Sample Name
Sample Code
 +6.89%
Sample Name
Sample Code
 +5.36%
4
Chagee Holdings
CHA
+3.18%
5
Qifu Technology
QFIN
+0.60%
View More
Middle East conflict spreads to the stock market! How should investors respond?
In the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US side, indicating that talks could resume i Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -